Literature DB >> 16909813

Extramedullary plasmacytoma of the nasal cavity: treatment perspective in a developing nation.

Nancy Grover1, Geetha Chary, Purnima Makhija, Pritilata Rout.   

Abstract

Extramedullary plasmacytomas are uncommon tumors, with a worldwide annual incidence of 3 per 100,000 population. They account for 1% of all tumors of the head and neck and 4% of all nonepithelial tumors of the nasal tract. A variety of treatment options has been suggested. These treatments vary according to the site of presentation, the presence of locoregional spread, and the histologic picture. Radiotherapy has been widely used as a treatment modality, but little has been written about surgery as a single management modality. However, such an option assumes importance in a developing nation, where patient follow-up is erratic and treatment costs must be kept low. We discuss the feasibility of surgery in such a circumstance, and we describe our surgical treatment of a case of extramedullary plasmacytoma in an elderly woman who presented to our hospital in India.

Entities:  

Mesh:

Year:  2006        PMID: 16909813

Source DB:  PubMed          Journal:  Ear Nose Throat J        ISSN: 0145-5613            Impact factor:   1.697


  4 in total

1.  Solitary Extramedullary Plasmacytoma of the Sphenoid Sinus: A Case Report.

Authors:  Siow Ping Loong; Ahmad Nordin Afandi; Chee Lun Lum; Cheng Ai Ong
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-12-21

2.  Solitary extramedullary plasmacytoma of the sinonasal region.

Authors:  Produl Hazarika; R Balakrishnan; Rohit Singh; Kailesh Pujary; Benazim Aziz
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2011-04-03

3.  Extramedullary Plasmacytoma of the Paranasal Sinuses: Combining Surgery with External Radiotherapy.

Authors:  Diana Vlad; Veronica Trombitas; Silviu Albu
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2015-01-25

4.  Extramedullary plasmacytoma of the nasal inferior turbinate: a case report.

Authors:  Yan Liu; Xiaopei Yuan; Xiaohong Peng; Zhiming Xing; Lisheng Yu
Journal:  J Int Med Res       Date:  2021-12       Impact factor: 1.671

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.